NEW YORK (GenomeWeb News) – MDx Health and HistoGeneX today announced a collaboration to provide molecular diagnostic testing services to drug manufacturers and oncologists.

Under the terms of the deal, MDxHealth will combine its epigenetics technologies with HistoGeneX's pharmacodiagnostic services. HistoGeneX's laboratory in Belgium will also provide MGMT methylation service testing for MDxHealth's clients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.